When we talk about estrogen, most people—and even many clinicians—focus on estradiol (E2). It’s known as the “strongest” estrogen and plays a dominant role in reproductive health, metabolism, and brain function. It is also the most commonly administered bioidentical estrogen. But there’s another estrogen that becomes especially important in midlife and beyond: estrone (E1). Understanding estrone can help explain why weight gain, obesity, menopause, and weight loss dramatically change how women feel—and why hormone balance becomes more complex over time. We also know that testing just estradiol levels may not tell the whole estrogen story in every woman.
What Is Estrone (E1)?
Estrone is one of the three primary estrogens:
- Estradiol (E2) – most potent, dominant in reproductive years
- Estriol (E3) – weakest, prominent in pregnancy
- Estrone (E1) – the dominant estrogen after menopause
At the receptor level, estradiol is 4–25 times more potent than estrone, which is why estrone has historically been labeled a “weak” estrogen, and why it alone didn’t reliably treat hormonal symptoms. . However, that description is newly known to be incomplete.
Important nuance:
- Estrone can be converted into estradiol and vice versa
- Estrone circulates in higher levels after menopause
- Estrone can exert independent biological effects, especially in:
- Brain function
- Immune signaling
- Inflammation
- Breast tissue
- Prolactin biology
- Vascular health
So while estrone may be “weaker” in classical receptor binding, it is not insignificant. In some non-genomic pathways, estrone can behave much more similarly to estradiol.
Where Does Estrone Come From?
Before menopause, estrogen is primarily produced by the ovaries.
After menopause, things shift:
Estrone becomes the dominant estrogen
It is made mostly in fat (adipose) tissue
It is produced through aromatization (conversion of androgens into estrogen)
Estrone, Weight Gain, and Obesity
This is where estrone becomes especially relevant.
The key concept: fat tissue makes estrogen—specifically estrone
The more adipose tissue you have, the more:
- Aromatase activity increases
- Androgens get converted into estrone
- Circulating estrone levels rise
In overweight or obese individuals:
- Higher estrone levels
- Higher estrone-to-estradiol ratio
- Chronic low-grade inflammation
- Altered metabolic signaling
- Increased risk for estrogen-sensitive conditions, insulin resistance, and fatigue
- Increased risk of breast and uterine lining endometrial cancer
This is why obesity is often described as a state of estrogen excess—but imbalance.
Estrone in Menopause: A Hormonal Pivot
After menopause:
- Estradiol drops dramatically
- Estrone declines more slowly
- Estrone levels end up about four times higher than estradiol
- Peripheral (fat-based) estrogen production becomes dominant
What this means:
Even though estrogen overall is reduced, the type of estrogen shifts.
Instead of a dynamic, ovarian-driven estradiol environment, you now have:
- Lower total estrogen
- Estrone-dominant physiology
- Less precise hormonal signaling
Clinical relevance:
This shift may contribute to:
- Brain fog
- Mood changes
- Sleep disruption
- Changes in fat distribution
- Increased cardiovascular risk
Weight Loss in Menopause: What Happens to Estrone?
This is where things get especially important.
When a menopausal woman loses weight:
- Fat mass decreases
- Aromatase activity decreases
- Estrone production drops
Possible consequences:
Lower estrone levels can:
- Improve inflammation and metabolic health
- Reduce estrogen-sensitive disease risk
But also may:
- Reveal underlying estrogen deficiency symptoms
- Temporarily worsen hot flashes, sleep issues, and mood
Why Some Women Feel Worse Before They Feel Better
During weight loss, especially rapid fat loss:
- Estrone stored in fat tissue declines
- Hormonal buffering is reduced
- Total estrogen burden drops further
This can create a temporary state of relative estrogen deficiency.
Even though long-term benefits are positive, short-term symptoms may include:
- Fatigue
- Mood swings
- Increased hot flashes
- Sleep disruption
Rethinking Estrone: Not Just a “Weak Estrogen”
Emerging science challenges the outdated idea that estrone is simply inferior to estradiol.
Current perspective:
- Estrone is a biologically active hormone, not just a precursor
- It may influence brain signaling, immune responses, breast tissue biology, and vascular health
- Its effects depend on tissue type, conversion to estradiol, and receptor-level behavior
This has important implications for:
- Hormone replacement therapy (HRT)
- Weight management strategies
- Personalized menopause care
Putting It All Together
In your 30s–40s
- Estradiol dominates
- Estrone plays a secondary role
With weight gain
- Estrone increases
- Inflammation and metabolic disruption rise
After menopause
- Estrone becomes the primary estrogen
- Hormonal signaling becomes less efficient
With weight loss after menopause
- Estrone decreases
- Metabolic health improves
- Symptoms may temporarily intensify
Takeaway: Balance Matters More Than Strength
Estrone is not simply the “weak estrogen.”
It is a context-dependent hormone whose impact is shaped by:
- Body composition
- Menopausal status
- Tissue-specific activity
- Conversion into estradiol
Understanding estrone helps explain why:
- Weight has powerful hormonal effects
- Menopause feels so different
- Fat loss can both help and temporarily challenge the body
Clinical Insight
For women navigating menopause and weight loss:
- Focus on gradual, sustainable fat loss
- Support metabolic health, especially insulin sensitivity and inflammation
- Consider hormone evaluation when symptoms emerge or persist
- Consider hormone therapy as prevention of hormonal symptoms if you are the age of perimenopause and embarking on a weight loss journey
- Individualize treatment rather than relying only on lab numbers
